{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:16:14Z","timestamp":1789013774982,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Leukapheresis (LA) in pediatric leukemia is performed for leukostasis, a life-threatening emergency in the setting of extremely increased blast cell counts. The authors aimed to assess the epidemiology of pediatric leukemia who received LA. The authors reviewed US nationally representative admission records of patients less than 20 years of age in the Kids\u2019 Inpatient Database for the years 2000, 2003, 2006, 2009, 2012, and 2016. Incidence of new leukemia cases who underwent LA were calculated for the years 2009, 2012, and 2016. Cox and logistic regression analyses were performed to ascertain the risk factors for adverse outcomes. There were 526 admissions for pediatric patients with acute lymphoblastic leukemia (ALL) (n=328), acute myeloid leukemia (AML) (n=124), or chronic myeloid leukemia (CML) (n=74) who underwent LA over the study period. The incidence of leukemia cases that required LA was lower in 2016 than in 2009 or 2012 (1.4%, 2.2%, and 2.7%, respectively; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001). In-hospital mortality was higher in AML than ALL (hzard ratio, 3.2; 95% confidence interval, 1.1-9.1). None with CML died during admission. This first population-based study of LA in pediatric leukemia showed a decreased utilization of LA over recent years. The higher inpatient mortality in AML, as compared with ALL or CML, warrant further investigations.<\/jats:p>","DOI":"10.1097\/mph.0000000000002140","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T13:02:22Z","timestamp":1616072542000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic Leukapheresis in Pediatric Leukemia: Utilization Trend and Early Outcomes in a US Nationwide Cohort"],"prefix":"10.1097","volume":"44","author":[{"given":"Takuto","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie M.","family":"Turcotte","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Rubin","sequence":"additional","affiliation":[{"name":"Biostatistics Core, Masonic Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan G.","family":"Spector","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(85)90544-3","article-title":"Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis","volume":"79","author":"Lester","year":"1985","journal-title":"Am J Med"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009053534","article-title":"Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management","volume":"39","author":"Porcu","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.transci.2016.12.001","article-title":"Effect of leukapheresis on blood coagulation in patients with hyperleukocytic acute myeloid leukemia","volume":"56","author":"Van de Louw","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1537-2995.1978.18178118553.x","article-title":"Rapid cytoreduction in acute leukemia. Management of cerebral leukostasis by cell pheresis","volume":"18","author":"Eisenstaedt","year":"1978","journal-title":"Transfusion"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0002-9343(79)90256-0","article-title":"Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia. Relationship of oxygen transfer to leukocyte count","volume":"67","author":"Bloom","year":"1979","journal-title":"Am J Med"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archinte.1981.00340100109024","article-title":"Chronic granulocyte leukemia with respiratory distress. Efficacy of emergency leukapheresis","volume":"141","author":"Karp","year":"1981","journal-title":"Arch Intern Med"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2141.1984.tb02190.x","article-title":"Hyperleucocytic retinopathy in chronic granulocytic leukaemia: the role of intensive leucapheresis","volume":"56","author":"Mehta","year":"1984","journal-title":"Br J Haematol"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1537-2995.2007.01406.x","article-title":"Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis","volume":"47","author":"Bug","year":"2007","journal-title":"Transfusion"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/bjh.14692","article-title":"Hyperleucocytosis in paediatric acute myeloid leukaemia\u2014the challenge of white blood cell counts above 200 x 10(9) \/l. The NOPHO experience 1984-2014","volume":"178","author":"Zeller","year":"2017","journal-title":"Br J Haematol"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cncr.23581","article-title":"Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis","volume":"113","author":"Inaba","year":"2008","journal-title":"Cancer"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pbc.25855","article-title":"Exchange transfusion and leukapheresis in pediatric patients with AML with high risk of early death by bleeding and leukostasis","volume":"63","author":"Creutzig","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2016.1277386","article-title":"Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis\u2014a retrospective study from a tertiary center","volume":"58","author":"Nan","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190109097677","article-title":"Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival","volume":"42","author":"Giles","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ajh.20939","article-title":"Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage","volume":"82","author":"Chang","year":"2007","journal-title":"Am J Hematol"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.13146","article-title":"A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis","volume":"168","author":"Kuo","year":"2015","journal-title":"Br J Haematol"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.transci.2017.11.002","article-title":"Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis","volume":"56","author":"Malkan","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2014.01.004","article-title":"Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis","volume":"38","author":"Oberoi","year":"2014","journal-title":"Leuk Res"},{"key":"R18-20250805","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"R19-20250805","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"R21-20250805","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1200\/JCO.1985.3.12.1590","article-title":"Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia","volume":"3","author":"Bunin","year":"1985","journal-title":"J Clin Oncol"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI107191","article-title":"Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations","volume":"52","author":"Lichtman","year":"1973","journal-title":"J Clin Invest"},{"key":"R28-20250805","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/trf.14329","article-title":"The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study","volume":"58","author":"Choi","year":"2018","journal-title":"Transfusion"},{"key":"R29-20250805","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MPH.0000000000000490","article-title":"Early complications of hyperleukocytosis and leukapheresis in childhood acute leukemias","volume":"38","author":"Abla","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"R30-20250805","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3109\/10428194.2013.850685","article-title":"Early deaths in pediatric acute leukemia: a population-based study","volume":"55","author":"Cheng","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R31-20250805","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/1097-0142(19871215)60:12<3071::AID-CNCR2820601235>3.0.CO;2-Y","article-title":"Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia","volume":"60","author":"Creutzig","year":"1987","journal-title":"Cancer"},{"key":"R32-20250805","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.V79.4.871.bloodjournal794871","article-title":"Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis","volume":"79","author":"Eguiguren","year":"1992","journal-title":"Blood"},{"key":"R33-20250805","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias\u2014an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front Pediatr"},{"key":"R34-20250805","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12288-010-0026-2","article-title":"Chronic myeloid leukemia presenting with visual and auditory impairment in an adolescent: an insight to management strategies","volume":"26","author":"Gokce","year":"2010","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R35-20250805","first-page":"500","article-title":"Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis","volume":"17","author":"Bubala","year":"2004","journal-title":"Pol Merkur Lekarski"},{"key":"R36-20250805","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.transci.2012.03.012","article-title":"Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia","volume":"46","author":"Veljkovic","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"R37-20250805","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mpo.2950150503","article-title":"Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children","volume":"15","author":"Bunin","year":"1987","journal-title":"Med Pediatr Oncol"},{"key":"R38-20250805","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","article-title":"Systematic review of discharge coding accuracy","volume":"34","author":"Burns","year":"2012","journal-title":"J Public Health (Oxf)"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:00:48Z","timestamp":1754355648000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002140","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"2020-10-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}